SCHEMBL23101917

SCHEMBL23101917

CCC(C)c1c(F)ccc(F)c1Cl

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR2A P28223 2/20 0.36
▸ HTR2C P28335 2/20 0.36
▸ MET P08581 8/20 0.34
▸ CA1 P00915 1/20 0.33
▸ CA2 P00918 1/20 0.33
▸ TSHR P16473 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ NPSR1 Q6W5P4 1/20 0.32
▸ SRC P12931 2/20 0.31
▸ KDR P35968 2/20 0.31
▸ KIT P10721 1/20 0.31
▸ FGFR2 P21802 1/20 0.31
▸ AXL P30530 1/20 0.31
▸ FLT3 P36888 1/20 0.31
▸ MST1R Q04912 1/20 0.31
▸ TNF P01375 1/20 0.31
▸ RIPK1 Q13546 1/20 0.31
▸ INPPL1 O15357 2/20 0.30
▸ PGR P06401 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14958569 0.85 MET (0.37) HTR2AHTR2CMETINPPL1
SCHEMBL23046940 0.80 TSHR (0.34) CA1CA2TSHRPGR
SCHEMBL22166119 0.78 TSHR (0.34) TSHRNPSR1
SCHEMBL12295184 0.78 MET (0.37) HTR2AHTR2CMETSRCKDR
SCHEMBL16590512 0.76 TAAR1 (0.40) TSHRMEN1KMT2ANPSR1RIPK1
SCHEMBL20097032 0.76 TSHR (0.38) HTR2AHTR2CTSHRMEN1KMT2A
SCHEMBL10250747 0.76 TSHR (0.40) HTR2AHTR2CTSHR
SCHEMBL13390274 0.75 MET (0.40) METSRCKDRKITFGFR2
SCHEMBL488432 0.74 MET (0.36) HTR2AHTR2CMETMEN1KMT2A
SCHEMBL1582536 0.74 MET (0.36) HTR2AHTR2CMETMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11344549-B2 2-substituted pyrazole amino-4-substituted amino-5-pyrimidine formamide compound, composition, and application thereof BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED (CN) 2022-05-31 — — US disclosed
US-20210077489-A1 2-SUBSTITUTED PYRAZOLE AMINO-4-SUBSTITUTED AMINO-5-PYRIMIDINE FORMAMIDE COMPOUND, COMPOSITION, AND APPLICATION THEREOF BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED (CN) 2021-03-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210077489-A1 2-SUBSTITUTED PYRAZOLE AMINO-4-SUBSTITUTED AMINO-5-PYRIMIDINE FORMAMIDE COMPOUND, COMPOSITION, AND APPLICATION THEREOF JAK1, JAK3, JAK2 HTR2A 3403/4885HTR2C 2145/4885MET 1469/4885
US-11344549-B2 2-substituted pyrazole amino-4-substituted amino-5-pyrimidine formamide compound, composition, and application thereof JAK1, JAK3, JAK2 HTR2A 3403/4885HTR2C 2145/4885MET 1469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback